findmyKOL
Clinical trialNCT06139094CompletedObservational

MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR

SponsorGenetesis Inc.Enrollment48AnginaCoronary Microvascular DiseaseIschemic Heart Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Florida

    Gainesville, Florida, United States

  • Ascension St. John Hospital

    Detroit, Michigan, United States

  • the Christ Hospital

    Cincinnati, Ohio, United States

  • the Cleveland Clinic Foundation

    Cleveland, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Dec 2023
Primary completion
13 May 2024
Completion
13 May 2024
Last update posted
31 May 2024
Registered enrollment
48
Registry id
NCT06139094

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.